BIOMARKER:

TA-MUC1-H + EGFR positive

Contact us to learn more about our Premium Content:

News alerts, weekly reports and conference planners

Entrez ID:

Related biomarkers:

‹

›

TA-MUC1-H + EGFR positive	Colorectal Cancer	TA-MUC1-H + EGFR positive	Colorectal Cancer	gatipotuzumab + tomuzotuximab Sensitive: C3 – Early Trials gatipotuzumab + tomuzotuximab Sensitive : C3	gatipotuzumab + tomuzotuximab Sensitive: C3 – Early Trials gatipotuzumab + tomuzotuximab Sensitive : C3
TA-MUC1-H + EGFR positive	Breast Cancer	TA-MUC1-H + EGFR positive	Breast Cancer	gatipotuzumab + tomuzotuximab Sensitive: C3 – Early Trials gatipotuzumab + tomuzotuximab Sensitive : C3	gatipotuzumab + tomuzotuximab Sensitive: C3 – Early Trials gatipotuzumab + tomuzotuximab Sensitive : C3
TA-MUC1-H + EGFR positive	Head and Neck Cancer	TA-MUC1-H + EGFR positive	Head and Neck Cancer	gatipotuzumab + tomuzotuximab Sensitive: C3 – Early Trials gatipotuzumab + tomuzotuximab Sensitive : C3	gatipotuzumab + tomuzotuximab Sensitive: C3 – Early Trials gatipotuzumab + tomuzotuximab Sensitive : C3
TA-MUC1-H + EGFR positive	Non Small Cell Lung Cancer	TA-MUC1-H + EGFR positive	Non Small Cell Lung Cancer	gatipotuzumab + tomuzotuximab Sensitive: C3 – Early Trials gatipotuzumab + tomuzotuximab Sensitive : C3	gatipotuzumab + tomuzotuximab Sensitive: C3 – Early Trials gatipotuzumab + tomuzotuximab Sensitive : C3